4//SEC Filing
BRYCE RICHARD PAUL 4
Accession 0001209191-20-041329
CIK 0001401667other
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 8:02 PM ET
Size
5.5 KB
Accession
0001209191-20-041329
Insider Transaction Report
Form 4
BRYCE RICHARD PAUL
SR VP, CLINICAL RESEARCH & DEV
Transactions
- Sale
COMMON STOCK
2020-07-02$10.67/sh−660$7,040→ 77,083 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.5701 to $10.6676, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
PUMA BIOTECHNOLOGY, INC.
CIK 0001401667
Entity typeother
Related Parties
1- filerCIK 0001553037
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 8:02 PM ET
- Size
- 5.5 KB